ASCO 2021 Lung Cancer In-depth

Demographic Disparities in Uptake of Lung Cancer Screening

Results of a retrospective analysis identified differences in completion of LDCT screening among racial and ethnic groups and between the sexes in each group.

Racial Disparities in Biomarker Testing, Clinical Trial Participation Affect Outcomes in NSCLC

Results of a retrospective analysis detected racial disparities in rates of biomarker testing and clinical trial participation among patients with NSCLC.

Prognostic Understanding Influences Patients’ Lung Cancer Care Decisions at the End of Life

Researchers assessed the associations between patients’ understanding of their prognosis and their end-of-life care decisions.

Multidisciplinary Response Program Improves Follow-up, Referrals for Suspicious Lung Nodules

Researchers present data on a program designed to increase completion rates among patients with suspicious lung nodules on screening CT.

Prediction Model Assesses Risk of Brain Metastasis in Patients With Non-Small Cell Lung Cancer

Researchers present their prediction model for assessing risk of brain metastases in patients with non-small cell lung cancer.

Percepta Genomic Sequencing Classifier May Improve Clinical Decision Making Regarding Lung Nodules

Researchers present data that demonstrate how the Percepta Genomic Sequencing Classifier can enhance care decisions regarding lung nodules.